Latvian fund LongeVC invests in medical startup SiPhox Health

Latvian venture fund LongeVC has invested in US medical startup SiPhox Health, which produces home blood test kits.

SiPhox Health was founded by Diedrik Vermeulen and Michael Dubrovsky in Burlington (US) in 2020. SiPhox Health offers a health testing option with in-home sensors and mail-in kits. The kit includes lancets (medical implements used in blood sampling) and devices to put blood samples inside. The company uses silicon photonic chip technology for health testing devices. This technology can detect diseases at an early stage such as cardiovascular disease, diabetes and hormonal imbalances.

In 2023 LongeVC and Jaan Tallinn’s fund Metaplanet invested in SiPhox Health.  Since then, the company has doubled its revenue in 2024 and expanded to 45 employees by early 2025. 

Founded in 2016 by Garri Zmudze, Sergey Jakimov, and Ilya Suharenko, LongeVC is a venture company with offices in Riga and Lugano (Switzerland). A €35M fund backs startups at the early and seed stage startups in the US and Europe.